Ignite Creation Date:
2024-05-05 @ 5:19 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00433914
Status:
COMPLETED
Last Update Posted:
2015-03-06
First Post:
2007-02-09
Brief Title:
Safety Tolerability and Immunogenicity of Two Different Formulations of Meningococcal B Recombinant Vaccine When Administered to Healthy Infants
Sponsor:
Novartis Vaccines
Organization:
Novartis
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Meningococcal Disease |
Keywords:
| Name | View |
|---|---|
| Meningococcal disease prevention vaccination | View |